Lumos Diagnostics Holdings Company Description

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia.

Its products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19.

It also offers disposable, Lumos Leelu, and hand-held readers. The company was incorporated in 2018 and is based in Carlsbad, California.

Lumos Diagnostics Holdings Limited

Country	Australia
Founded	2018
Industry	Medical Devices
Sector	Healthcare
CEO	Douglas Ward

Contact Details

Address: 2724 Loker Ave West Carlsbad, Victoria 92010 United States
Phone	855 586 6739
Website	lumosdiagnostics.com

Stock Details

Ticker Symbol	LDX
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	USD
ISIN Number	AU0000157091
SIC Code	3829

Key Executives

Name	Position
Douglas Ward	Chief Executive Officer, MD and Director
Barrie Lambert	Chief Financial Officer
Dr. Sacha Dopheide Ph.D.	Chief Technology Officer
Sarah Glubka	Senior Director of Human Resources
Paul Kase	Senior Vice President of Commercial Operations
Tracy Weimar BA, MBA	Company Secretary